Three signals are now moving in the same direction on VERX. Short sellers are covering, borrow costs have collapsed, and yet options traders just printed the most defensive read in months. The data points don't fully agree — and that tension is worth watching ahead of Wednesday's earnings.
The cost to borrow VERX shares fell 71% in a week to just 0.13% — the lowest level on record in this dataset. A month ago it sat above 0.85%. Availability is now at 2,337%, meaning roughly 23 shares remain available in the lending pool for every one currently borrowed. That is an extremely loose borrow market. Short sellers face no structural friction here.
The ORTEX short score has also eased, dropping from 53.6 on July 20 to 48.7 as of July 31. That move tracks the broader short-covering trend: SI fell roughly 12.9% over the past week to 9.4% of free float. Bears have been reducing exposure since mid-July, when shares outstanding short peaked above 8.4 million. The current estimate is closer to 7.3 million.
The put/call ratio hit 0.50 on August 3 — a 1.12 standard deviation move above the 20-day mean of 0.039. That PCR level is still very low in absolute terms, but the jump is notable given how consistently call-dominated VERX options flow has been. As covered in a previous ORTEX note, the more dramatic PCR spike earlier this week reached 4.35 standard deviations — an extraordinary break from the stock's usual pattern.
The single prior earnings reaction on record — the June print — resulted in a 4.9% single-day drop and a 10.3% decline over five days. Earnings are scheduled for August 5.
Morgan Stanley downgraded VERX to Equal-Weight on July 21, cutting the price target from $19 to $15. That followed a wave of target reductions in February from Citigroup, Goldman Sachs, BMO Capital, and others. TD Cowen initiated with a Buy at $14 in late June. The consensus target stands at $17.15 against a current price of $13.40 — a gap of roughly 28%.
The Benzinga bull case points to the Brinta acquisition, SAP partnership activity, and AI-driven upsell potential. The bear case flags the delayed EBITDA margin timeline — now targeting FY27 instead of FY25 — as evidence of execution risk. BlackRock added 200,419 shares as of June 30; that's a notable institutional build from one of the larger passive managers in the register.
See the live data behind this article on ORTEX.
Open VERX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
